ondansetron hydrochloride + sumatriptan

**Ondansetron hydrochloride + sumatriptan** is an oral fixed-combination product or kit pairing the antiemetic **ondansetron**, a selective serotonin 5-HT3 receptor antagonist, with **sumatriptan**, a serotonin 5-HT1B/5-HT1D receptor agonist used for acute migraine treatment. The combination appears intended to address both migraine pain and associated nausea/vomiting in patients with migraine. Publicly identifiable evidence supports the existence of an unapproved U.S. product labeled **Sumansetron**, packaged by PureTek, but the available DailyMed record is internally inconsistent and primarily reproduces ondansetron labeling text rather than a clear, fully characterized combination-drug label; accordingly, this asset should be treated as a real but poorly documented combination product rather than a well-established approved branded medicine.

Brand names

Sumansetron

Other names

ondansetron hydrochloride + sumatriptansumatriptan succinate + ondansetron